Genus plc (LON:GNS - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2,646.68 and traded as high as GBX 2,650. Genus shares last traded at GBX 2,624, with a volume of 2,511,802 shares changing hands.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Shore Capital Group reissued a "buy" rating and set a GBX 3,000 target price on shares of Genus in a report on Friday, January 16th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a "buy" rating in a report on Friday, January 16th. Finally, Berenberg Bank reissued a "buy" rating and set a GBX 3,350 target price on shares of Genus in a research note on Wednesday, April 1st. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, Genus has an average rating of "Buy" and an average price target of GBX 3,216.67.
Check Out Our Latest Stock Report on Genus
Genus Stock Performance
The company has a 50 day simple moving average of GBX 2,810.36 and a 200-day simple moving average of GBX 2,646.68. The stock has a market capitalization of £1.74 billion, a price-to-earnings ratio of 36.96, a price-to-earnings-growth ratio of 2.87 and a beta of 0.85. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 55.10.
Genus (LON:GNS - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported GBX 60.80 earnings per share for the quarter. Genus had a return on equity of 9.70% and a net margin of 7.07%. As a group, equities research analysts expect that Genus plc will post 70.9644323 EPS for the current fiscal year.
Insider Transactions at Genus
In related news, insider Celia Baxter purchased 1,728 shares of Genus stock in a transaction that occurred on Friday, February 27th. The shares were acquired at an average cost of GBX 2,893 per share, for a total transaction of £49,991.04. 0.70% of the stock is currently owned by insiders.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
